PubMed (GeneRIF) for id: 3055

Year	Number of Results
1991	1
2000	1
2001	1
2002	1
2003	3
2004	4
2005	3
2006	2
2007	5
2008	2
2009	2
2010	6
2011	4
2012	5
2013	3
2014	1
2015	1
2016	3
2017	3
2018	2
2019	2
2020	5
2021	4
2022	3
2023	1
2024	0

1

HCK Promotes High-Grade Serous Ovarian Cancer Tumorigenesis through CD44 and NOTCH3 Signaling.

Khella CA, Franciosa L, Rodirguez-Rodriguez L, Rajkarnikar R, Mythreye K, Gatza ML. Khella CA, et al. Mol Cancer Res. 2023 Oct 2;21(10):1037-1049. doi: 10.1158/1541-7786.MCR-22-0496. Mol Cancer Res. 2023. PMID: 37342066

2

Kinase-deficient BTK mutants confer ibrutinib resistance through activation of the kinase HCK.

Dhami K, Chakraborty A, Gururaja TL, Cheung LW, Sun C, DeAnda F, Huang X. Dhami K, et al. Sci Signal. 2022 May 31;15(736):eabg5216. doi: 10.1126/scisignal.abg5216. Epub 2022 May 31. Sci Signal. 2022. PMID: 35639855

3

HCK is a Potential Prognostic Biomarker that Correlates with Immune Cell Infiltration in Acute Myeloid Leukemia.

Cheng F, Li Q, Wang J, Wang L, Li W, Zeng F. Cheng F, et al. Dis Markers. 2022 Mar 4;2022:3199589. doi: 10.1155/2022/3199589. eCollection 2022. Dis Markers. 2022. PMID: 35280440 Free PMC article.

4

A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas.

Munshi M, Liu X, Kofides A, Tsakmaklis N, Guerrera ML, Hunter ZR, Palomba ML, Argyropoulos KV, Patterson CJ, Canning AG, Meid K, Gustine J, Branagan AR, Flynn CA, Sarosiek S, Castillo JJ, Wang J, Buhrlage SJ, Gray NS, Munshi NC, Anderson KC, Treon SP, Yang G. Munshi M, et al. Blood Adv. 2022 Jun 14;6(11):3332-3338. doi: 10.1182/bloodadvances.2021006147. Blood Adv. 2022. PMID: 35255496 Free PMC article.

5

HCK maintains the self-renewal of leukaemia stem cells via CDK6 in AML.

Li Z, Wang F, Tian X, Long J, Ling B, Zhang W, Xu J, Liang A. Li Z, et al. J Exp Clin Cancer Res. 2021 Jun 24;40(1):210. doi: 10.1186/s13046-021-02007-4. J Exp Clin Cancer Res. 2021. PMID: 34167558 Free PMC article.

6

miR-181b and miR-204 suppress the VSMC proliferation and migration by downregulation of HCK.

Ghasempour G, Mahabadi VP, Shabani M, Mohammadi A, Zamani-Garmsiri F, Amirfarhangi A, Karimi M, Najafi M. Ghasempour G, et al. Microvasc Res. 2021 Jul;136:104172. doi: 10.1016/j.mvr.2021.104172. Epub 2021 Apr 21. Microvasc Res. 2021. PMID: 33894273

7

Selective targeting of the inactive state of hematopoietic cell kinase (Hck) with a stable curcumin derivative.

Chakraborty MP, Bhattacharyya S, Roy S, Bhattacharya I, Das R, Mukherjee A. Chakraborty MP, et al. J Biol Chem. 2021 Jan-Jun;296:100449. doi: 10.1016/j.jbc.2021.100449. Epub 2021 Feb 20. J Biol Chem. 2021. PMID: 33617879 Free PMC article.

8

HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients.

Zhu X, Zhang Y, Bai Y, Gu X, Chen G, Sun L, Wang Y, Qiao X, Ma Q, Zhu T, Bu J, Xue J, Liu C. Zhu X, et al. Int J Med Sci. 2020 Sep 30;17(17):2773-2789. doi: 10.7150/ijms.43161. eCollection 2020. Int J Med Sci. 2020. PMID: 33162805 Free PMC article.

9

Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma.

Lantermans HC, Minderman M, Kuil A, Kersten MJ, Pals ST, Spaargaren M. Lantermans HC, et al. Leukemia. 2021 Mar;35(3):881-886. doi: 10.1038/s41375-020-0934-6. Epub 2020 Jun 26. Leukemia. 2021. PMID: 32591642 Free PMC article.

10

HCK promotes glioblastoma progression by TGFβ signaling.

Wang Z, Ying C, Zhang A, Xu H, Jiang Y, Lou M. Wang Z, et al. Biosci Rep. 2020 Jun 26;40(6):BSR20200975. doi: 10.1042/BSR20200975. Biosci Rep. 2020. PMID: 32484210 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

58 results

Results by year